Utility of p40 in the Differential Diagnosis of Small Round Blue Cell Tumors of the Sinonasal Tract

Head and Neck Pathology

Volumn 8, Issue 2, 2014, Pages 141-145

  Tilson, Matthew P ^a,b   Bishop, Justin A ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Esthesioneuroblastoma; p40; p63; Small round blue cell; Squamous cell carcinoma; Tumor

Indexed keywords

CKAP4 PROTEIN, HUMAN; ISOPROTEIN; MEMBRANE PROTEIN; TUMOR MARKER;

BIOSYNTHESIS; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; NOSE NEOPLASMS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NOSE NEOPLASMS; PROTEIN ISOFORMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84900811522     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-013-0496-2     Document Type: Article

References (26)

1. Iezzoni JC, Mills SE. "Undifferentiated" small round cell tumors of the sinonasal tract: differential diagnosis update. Am J Clin Pathol. 2005;124(Suppl): S110-21.
2. Chapman-Fredricks J, Jorda M, Gomez-Fernandez C. A limited immunohistochemical panel helps differentiate small cell epithelial malignancies of the sinonasal cavity and nasopharynx. Appl Immunohistochem Mol Morphol. 2009;17(3): 207-10.
3. Bridge JA, Bowen JM, Smith RB. The small round blue cell tumors of the sinonasal area. Head Neck Pathol. 2010;4(1): 84-93.
4. Mills SE, Fechner RE. "Undifferentiated" neoplasms of the sinonasal region: differential diagnosis based on clinical, light microscopic, immunohistochemical, and ultrastructural features. Semin Diagn Pathol. 1989;6(4): 316-28.
5. Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. Am J Surg Pathol. 2011;35(12): 1786-93.
6. Bourne TD, Bellizzi AM, Stelow EB, Loy AH, Levine PA, Wick MR, et al. p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract. Am J Clin Pathol. 2008;130(2): 213-8.
7. Stelow EB, Mills SE. Neural, neuroectodermal, and neuroendocrine neoplasms. Biopsy interpretation of the upper aerodigestive tract and ear. Philadelphia: Lippincott Williams & Wilkins; 2008. p. 149.
8. Bishop JA, Teruya-Feldstein J, Westra WH, Pelosi G, Travis WD, Rekhtman N. p40 (DeltaNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma. Mod Pathol. 2012;25(3): 405-15.
9. Fukushima N, Satoh T, Sueoka N, Sato A, Ide M, Hisatomi T, et al. Clinico-pathological characteristics of p63 expression in B-cell lymphoma. Cancer Sci. 2006;97(10): 1050-5.
10. Emanuel P, Wang B, Wu M, Burstein DE. p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol. 2005;18(5): 645-50.
11. Park CK, Oh YH. Expression of p63 in reactive hyperplasias and malignant lymphomas. J Korean Med Sci. 2005;20(5): 752-8.
12. Crum CP, McKeon FD. P63 in epithelial survival, germ cell surveillance, and neoplasia. Ann Rev Pathol. 2010;5(Journal Article): 349-71.
13. Lin Z, Liu M, Li Z, Kim C, Lee E, Kim I. DeltaNp63 protein expression in uterine cervical and endometrial cancers. J Cancer Res Clin Oncol. 2006;132(12): 811-6.
14. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad USA. 2000;97(10): 5462-7.
15. Pelosi G, Sonzogni A, Papotti M, Righi L, Rossi G, Viale G. Different prevalence of transactivating (TA) p63 and non-TAp63 isoforms in pulmonary adenocarcinomas: a useful diagnostic tool. Mod Pathol. 2010;23(1s): 411A-2A.
16. Righi L, Graziano P, Fornari A, Rossi G, Barbareschi M, Cavazza A, et al. Immunohistochemical subtyping of nonsmall cell lung cancer not otherwise specified in fine-needle aspiration cytology: a retrospective study of 103 cases with surgical correlation. Cancer. 2011;117(15): 3416-23.
17. Del Vescovo V, Cantaloni C, Cucino A, Girlando S, Silvestri M, Bragantini E, et al. miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. Am J Surg Pathol. 2011;35(2): 268-75.
18. Bishop JA, Guo TW, Smith DF, Wang H, Ogawa T, Pai SI, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37(2): 185-92.
19. Tilson MP, Gallia GL, Bishop JA. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas. Head Neck Pathol. 2013. In Press. doi: 10. 1007/s12105-013-0475-7.
20. Bishop JA, Westra WH. NUT midline carcinomas of the sinonasal tract. Am J Surg Pathol. 2012;36(8): 1216-21.
21. French CA. NUT midline carcinoma. Cancer Genet Cytogenet. 2010;203(1): 16-20.
22. Stelow EB. A review of NUT midline carcinoma. Head Neck Pathol. 2011;5(1): 31-5.
23. Pelosi G, Fabbri A, Rossi G, Maisonneuve P, Sonzogni A, Bresaola E, et al. A two-hit minimalist diagnostic algorithm based on p40 (deltaNp63) and TTF-1 immunostaining upon small biopsy/cellblock samples for differentiating main subtypes of non-small cell lung cancer and sparing material. J Thorac Oncol. 2011;6(6): S335-6.
24. Uramoto H, Yamada S, Hanagiri T. Immunohistochemical staining with deltaNp63 is useful for distinguishing the squamous cell component of adenosquamous cell carcinoma of the lung. Anticancer Res. 2010;30(11): 4717-20.
25. Iacono ML, Monica V, Saviozzi S, Ceppi P, Bracco E, Papotti M, et al. p63 and p73 Isoform Expression in Non-small Cell Lung Cancer and Corresponding Morphological Normal Lung Tissue. J Thorac Oncol. 2011;6(3): 473-81.
26. Serrano MF, El-Mofty SK, Gnepp DR, Lewis JS Jr. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck. Hum Pathol. 2008;39(4): 591-8.